1-2 of 2
Rod Van Syoc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

Farhad Ravandi, MD, Camille N Abboud, MD, Luke Paul Akard, MD, Saar I. Gill, MDPhD, Jack W. Hsu, MD, Suman Kambhampati, MD, Irum Khan, MBBS, Delong Liu, MD PhD, Wendy Stock, MD, Janice W Brown, MD, Asad Bashey, MD PhD, Gautam Borthakur, MD, Courtney D. DiNardo, MDMSc, H. Kent Holland, MD, Tapan M. Kadia, MD, Hagop M. Kantarjian, MD, Lawrence E Morris, MD, Scott R Solomon, MD, Richard David Mamelok, MD, Swapna Panuganti, PhD, Rod Van Syoc, Alicia Wong, BS, Deborah Zimmerman, PhD, Melhem Solh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1407.
https://doi.org/10.1182/blood-2018-99-117231
Published: 2018
Journal Articles

Phase 1 Clinical Investigation of Human Myeloid Progenitor Cells (CLT-008) As a Supportive Care Measure during Chemotherapy for Acute Myeloid Leukemia (AML)

Matthew J. Wieduwilt, MD PhD, Jan Cerny, MD PhD, Luke Akard, MD, Celalettin Ustun, MD, Farhad Ravandi, MD, James M. Rossetti, DO, Brian T. Hill, MD PhD, Janice (Wes) Brown, MD, Lois Kellerman, Rod Van Syoc, William Reed, MD, Charalambos Andreadis, MD MSCE
Journal: Blood
Blood (2014) 124 (21): 2268.
https://doi.org/10.1182/blood.V124.21.2268.2268
Published: 2014